Medtronic plc, a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for its Mosaic Neo™ mitral bioprosthesis and has launched the valve in the U.S. This approval marks an important milestone for patients and clinicians.
[...]
This is an abstract of the document. To keep reading, click here and get access to the original version.